BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Roche (RHHBY) Launches New Bead Based DNA Target Enrichment Reagent Kit for Next Generation Sequencing


5/28/2013 11:36:11 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Penzberg, Germany and Madison, WI, USA, May 28, 2013 / B3C newswire / - Roche today announced the global launch of its SeqCap EZ Pure Capture Bead Kit supporting target enrichment workflows prior to DNA sequencing. The newly introduced SeqCap EZ Pure Capture Bead Kit is designed to provide sensitive and robust methods for capture and purification of DNA sample libraries enabling high-quality targeted sequencing results. With the addition of the new kit to its capture portfolio, Roche now offers SeqCap EZ Library probe pools and all target enrichment reagents in a one stop shop.

“This launch is another step in our continued and committed efforts to improve customer convenience and enhance the efficiency of genomics research based on our industry-leading target enrichment technology for next-generation sequencing,” said Thomas Schinecker, President Roche Sequencing Solutions.

Roche provides a comprehensive set of reagents and probe pools for superior target enrichment performance. The probe pools include exome libraries, gene panels and custom designs. Roche also launched a suite of SeqCap EZ reagent kits in January this year for applications in single or multiplex target enrichment experiments. With the recent addition, the comprehensive set of capture reagents will allow a more streamlined target enrichment workflow and ensure superior sequence capture efficiency.

For more information about Roche NimbleGen, please visit www.nimblegen.com

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Roche
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES